Cappello 09.10.2022

A new review discusses promising therapeutic approaches aimed at reprogramming macrophages in human cancer A recent review out this month in the prestigious journal Nature Reviews Drug Discovery, d…

Donatella Delle Cave, PhD

WHAT IS YOUR BACKGROUND? Since I was a little girl, I’ve yearned to know the why and the how of things. Growing up, that wish became interest in understanding the complexity of life. In parti…

Mjriam Capula, PhD

WHAT IS YOUR BACKGROUND?

Since I was a little girl, I’ve yearned to know the why and the how of things. Growing up, that wish became interest in understanding the complexity of life. In particul…

Carrer 3.14.22

WCRF grant for Dr. Carrer Congratulations to Dr. Alessandro Carrer, one of the founding members of I-PCC, for receiving the prestigious #WCRF grant to study “Whether the excessive ingestion of fructose, a widely popular …

Martini-Giovannetti

p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis Congratulations to I-PCC members Dr. Miriam Martini  and Dr. Elisa Giovannetti for their c…

IECC 2022 - Cappello

Congratulations to @Paola Cappello one of the founding members of @I-PCC for organizing the 2nd International Electronic Conference on Cancers (IECC 2022), entitled “Tumor Microenvironment Heterogeneity in Cancer Progress…

News Carmine Carbone 2.16.22

Pancreatic cancer: “Nab-PIPAC” for patients with peritoneal metastases The Foundation has launched the phase 2 Nab-PIPAC study, which will explore the results of administering the chemotherapeut…

Pierluigi Di Chiaro, PhD

WHAT IS YOUR BACKGROUND?

My first experience in cancer field was during my academic studies at the University of Bologna. I was intrigued by how cancer cells can trigger several molecular mec…

Claudia Curcio, PhD

WHAT IS YOUR BACKGROUND?

Since my undergraduate trainee I worked on tumor immunology and immunotherapy I got my Master degree in Turin and my thesis aimed at the demonstration that an anti-tumor…

IEO Diaferia

Researchers at European Institute of Oncology (IEO) described the complex heterogenicity of pancreatic cancer: a tale of two cell types and their many variants

Most of the human cancers are made…